✦ LIBER ✦

143 EFFICACY AND SAFETY OF INCREASING DOSES OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A IN TREATMENT NAIVE CHRONIC HCV PATIENTS

✍ Scribed by R. Flisiak; S.V. Feinman; M. Jablkowski; A. Horban; W. Kryczka; W. Halota; J.E. Heathcote; G. Mazzella; C. Vandelli; J.S. Liz; R. Crabbé; P. Scalfaro; H. Porchet

Book ID: 117376069
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 61 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60145-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

95 EFFICACY AND SAFETY OF THE CYCLOPHILI

95 EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS

✍ D.R. Nelson; R.H. Ghalib; M. Sulkowski; E. Schiff; V. Rustgi; P.J. Pockros; C. W 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

946 PK-PD MODELING OF VIRAL KINETICS DUR

946 PK-PD MODELING OF VIRAL KINETICS DURING TREATMENT WITH DEBIO-025 PLUS PEGYLATED INTERFERON ALPHA-2A IN TREATMENT-NAIVE HCV PATIENTS

✍ E. Herrmann; A. Käfer; R. Flisiak; V. Nicolas-Métral; S. Zeuzem; R. Crabbe 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 114 KB

[50] ANTIVIRAL ACTIVITY OF THE NON-NUCLE

[50] ANTIVIRAL ACTIVITY OF THE NON-NUCLEOSIDE POLYMERASE INHIBITOR, HCV-796, IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2b IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV

✍ S.A. Villano; D. Raible; D. Harper; J. Speth; P. Chandra; P. Shaw; G. Bichier 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 155 KB

[10] THE SAFETY AND EFFICACY OF TARIBAVI

[10] THE SAFETY AND EFFICACY OF TARIBAVIRIN PLUS PEGYLATED INTERFERON ALFA-2a VERSUS RIBAVIRIN PLUS PEGYLATED INTERFERON ALFA-2a IN THERAPY-NAIVE PATIENTS INFECTED WITH HCV: PHASE 3 RESULTS

✍ P. Marcellin; Y. Lurie; M. Rodrigues-Torres; R. Chasen; Y. Xu; B. Murphy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 117 KB

2009 SAFETY AND ANTIVIRAL ACTIVITY OF AN

2009 SAFETY AND ANTIVIRAL ACTIVITY OF ANA598 IN COMBINATION WITH PEGYLATED INTERFERON α2A PLUS RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 CHRONIC HCV PATIENTS

✍ Lawitz, E.; Rodriquez-Torres, M.; Rustgi, V.K.; Hassanein, T.; Rahimy, M.H.; Cro 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Safety and efficacy of an escalating dos

Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C

✍ S. S. Tan; M. R. Abu Hassan; A. Abdullah; B. P. Ooi; T. Korompis; M. I. Merican 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB